3-carboxy-4-methyl-5-propyl-2-furanpropionic acid has been researched along with diflunisal in 1 studies
| Studies (3-carboxy-4-methyl-5-propyl-2-furanpropionic acid) | Trials (3-carboxy-4-methyl-5-propyl-2-furanpropionic acid) | Recent Studies (post-2010) (3-carboxy-4-methyl-5-propyl-2-furanpropionic acid) | Studies (diflunisal) | Trials (diflunisal) | Recent Studies (post-2010) (diflunisal) |
|---|---|---|---|---|---|
| 100 | 6 | 38 | 605 | 129 | 145 |
| Protein | Taxonomy | 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid (IC50) | diflunisal (IC50) |
|---|---|---|---|
| Carbonic anhydrase 1 | Homo sapiens (human) | 3.38 | |
| Carbonic anhydrase 2 | Homo sapiens (human) | 2.7 | |
| Transthyretin | Homo sapiens (human) | 5.4667 | |
| Solute carrier family 22 member 6 | Homo sapiens (human) | 0.85 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barlow, JW; Curtis, AJ; Lim, CF; Stockigt, JR; Topliss, DJ; Wynne, KN | 1 |
1 other study(ies) available for 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and diflunisal
| Article | Year |
|---|---|
A naturally occurring furan fatty acid enhances drug inhibition of thyroxine binding in serum.
Topics: Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Binding, Competitive; Diflunisal; Dose-Response Relationship, Drug; Drug Interactions; Fatty Acids, Nonesterified; Furans; Furosemide; Humans; Oleic Acid; Oleic Acids; Phenylacetates; Prealbumin; Propionates; Thyroxine; Thyroxine-Binding Proteins; Triiodothyronine | 1993 |